Cooper Companies, Inc.

Record Financial Performance: Cooper Companies reported all-time record revenues of $3.9 billion for fiscal 2024, representing an 8% increase year-over-year. Q4 revenues were $1.018 billion, up 10% year-over-year and 7% organically, driven by strong performances in both CooperVision and CooperSurgical.

Guidance for Fiscal 2025: For fiscal 2025, CooperVision's revenue is forecasted to reach $2.733 billion to $2.786 billion, an organic growth of 6.5% to 8.5%. Overall, consolidated revenues are expected to be between $4.08 billion and $4.158 billion, implying 6% to 8% organic growth. The effective tax rate is anticipated to be slightly over 15%, and non-GAAP EPS is projected in the range of $3.92 to $4.02.

Challenges in Demand: The company experienced unexpected softness in demand particularly in the U.S. and China towards the end of Q4, influenced possibly by external factors like hurricanes or inventory adjustments. This may indicate potential volatility in sales momentum moving into fiscal 2025.